Non-Invasive Lung IMPEDANCE-Guided Preemptive Treatment in Chronic Heart Failure Patients: A Randomized Controlled Trial (IMPEDANCE-HF Trial)

Journal of Cardiac Failure

Volumn 22, Issue 9, 2016, Pages 713-722

  Shochat, Michael Kleiner ^a   Shotan, Avraham ^a   Blondheim, David S ^a   Kazatsker, Mark ^a   Dahan, Iris ^a   Asif, Aya ^a   Rozenman, Yoseph ^b   Kleiner, Ilia ^c   Weinstein, Jean Marc ^c   Frimerman, Aaron ^a   Vasilenko, Lubov ^a   Meisel, Simcha R ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Acute heart failure; chronic heart failure; lung impedance; monitoring heart failure

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FUROSEMIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MINERALOCORTICOID RECEPTOR; WARFARIN; PRE BETA HIGH DENSITY LIPOPROTEIN;

AGED; ARTICLE; CARDIOVASCULAR MORTALITY; CONTROLLED STUDY; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; FEMALE; FOLLOW UP; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; IMPEDANCE; LUNG CONGESTION; LUNG IMPEDANCE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEW YORK HEART ASSOCIATION CLASS; NON INVASIVE PROCEDURE; OUTCOME ASSESSMENT; OUTPATIENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; CHRONIC DISEASE; CLINICAL TRIAL; CONFIDENCE INTERVAL; DRUG EFFECTS; HEART STROKE VOLUME; LUNG EDEMA; LUNG FUNCTION TEST; MIDDLE AGED; MORTALITY; PHYSIOLOGY; PROGNOSIS; REFERENCE VALUE; SINGLE BLIND PROCEDURE; STATISTICS AND NUMERICAL DATA; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

AGED; CHRONIC DISEASE; CONFIDENCE INTERVALS; DIURETICS; ELECTRIC IMPEDANCE; FEMALE; HEART FAILURE; HIGH-DENSITY LIPOPROTEINS, PRE-BETA; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PULMONARY EDEMA; REFERENCE VALUES; RESPIRATORY FUNCTION TESTS; SINGLE-BLIND METHOD; STROKE VOLUME; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84964621652     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2016.03.015     Document Type: Article

References (20)

1. 1 Pascual-Figal, D.A., Casas, T., Ordonez-Llanos, J., Manzano-Fernández, S., Bonaque, J.C., Boronat, M., et al. Highly sensitive troponin T for risk stratification of acutely destabilized heart failure. Am Heart J 163 (2012), 1002–1010.
2. 2 Go, A.S., Mozaffarian, D., Roger, V.L., Benjamin, E.J., Berry, J.D., Blaha, M.J., et al. Heart disease and stroke statistics: 2014 update. A report from the American Heart Association. Circulation 129 (2014), e27–292.
3. 3 Abraham, W.T., Adamson, P.B., Bourge, R.C., Aaron, M.F., Costanzo, M.R., Stevenson, L.W., et al. Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomized controlled trial. Lancet 377 (2011), 658–666.
4. 4 Shochat, M., Charach, G., Meyler, S., Kazatsker, M., Mosseri, M., Frimerman, A., et al. Internal thoracic impedance monitoring: a novel method for the preclinical detection of acute heart failure. Cardiovasc Revasc Med 7 (2006), 41–45.
5. 5 Shochat, M., Charach, G., Meyler, S., Meisel, S., Weintraub, M., Mengeritsky, G., et al. Prediction of cardiogenic pulmonary edema onset by monitoring right lung impedance. Intensive Care Med 32 (2006), 1214–1221.
6. 6 Shochat, M., Shotan, A., Blondheim, D.S., Kazatsker, M., Dahan, I., Asif, A., et al. Usefulness of lung impedance-guided pre-emptive therapy to prevent pulmonary edema during ST-elevation myocardial infarction and to improve long- term outcomes. Am J Cardiol 110 (2012), 190–196.
7. 7 Shochat, M., Shotan, A., Trachtengerts, V., Blondheim, D.S., Kazatsker, M., Gurovich, V., et al. A novel radiological score to assess lung fluid content during evolving acute heart failure in the course of acute myocardial infarction. Acute Card Care 13 (2011), 81–86.
8. 8 Shochat, M., Shotan, A., Blondheim, D.S., Kazatsker, M., Dahan, I., Asif, A., et al. Derivation of baseline lung impedance in chronic heart failure patients: use for monitoring pulmonary congestion and predicting admissions for decompensation. J Clin Monit Comput 29 (2015), 341–349.
9. 9 Malfatto, G., Blengino, S., Perego, G.B., Branzi, G., Villani, A., Facchini, M., et al. Transthoracic impedance accurately estimates pulmonary wedge pressure in patients with decompensated chronic heart failure. Congest Heart Fail 18 (2012), 25–31.
10. 10 Packer, M., Abraham, W.T., Mehra, M.R., Yancy, C.W., Lawless, C.E., Mitchell, J.E., et al. Utility of impedance cardiography for the identification of short-term risk of clinical decompensation in stable patients with chronic heart failure. J Am Coll Cardiol 47 (2006), 2245–2252.
11. 11 Facchini, C., Malfatto, G., Giglio, A., Facchini, M., Parati, G., Branzi, G., Lung ultrasound and transthoracic impedance for noninvasive evaluation of pulmonary congestion in heart failure. J Cardiovasc Med (Hagerstown), 2015, 10.2459/JCM.0000000000000226 Jan 7 25575275 [E-pub ahead of print].
12. 12 McMurray, J.J., Adamopoulos, S., Anker, S.D., Auricchio, A., Böhm, M., Dickstein, K., et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J 33 (2012), 1787–1847.
13. 13 Gheorghiade, M., Follath, F., Ponikowski, P., Barsuk, J.H., Blair, J.E., Cleland, J.G., et al. Assessing and grading congestion in acute heart failure: a scientific statement from the acute heart failure committee of the heart failure association of the European Society of Cardiology and endorsed by the European Society of Intensive Care Medicine. Eur J Heart Fail 12 (2010), 423–433.
14. 14 Metra, M., O'Connor, C.M., Davison, B.A., Cleland, J.G., Ponikowski, P., Teerlink, J.R., et al. Early dyspnoea relief in acute heart failure: prevalence, association with mortality, and effect of rolofylline in the PROTECT Study. Eur Heart J 32 (2011), 1519–1534.
15. 15 Ilsar, R., Bailey, B.P., Dobbins, T.A., Celermajer, D.S., The relationship between pulmonary artery and pulmonary capillary wedge pressure for the diagnosis of pulmonary vascular disease. Heart Lung Circ 19 (2010), 38–42.
16. 16 Kovacs, G., Avian, A., Tscherner, M., Foris, V., Bachmaier, G., Olschewski, A., et al. Characterization of patients with borderline pulmonary arterial pressure. Chest 146 (2014), 1486–1493.
17. 17 Taylor, B.J., Mojica, C.R., Olson, T.P., Woods, P.R., Frantz, R.P., Johnson, B.D., A possible role for systemic hypoxia in the reactive component of pulmonary hypertension in heart failure. J Card Fail 19 (2013), 50–59.
18. 18 Goldenberg, N.M., Hare, G.M., From the Journal archives: understanding the mechanism(s) regulating hypoxic pulmonary vasoconstriction: how an early study has led to novel translational approaches. Can J Anaesth 61 (2014), 195–199.
19. 19 Van Veldhuisen, D.J., Braunschweig, F., Conraads, V., Ford, I., Cowie, M.R., Jondeau, G., et al. Intrathoracic impedance monitoring, audible patient alerts, and outcome in patients with heart failure. Circulation 124 (2011), 1719–1726.
20. 20 Charles, C.J., Rademaker, M.T., Melton, I.C., Gutfinger, D., Eigler, N.L., Qu, F., et al. Thoracic impedance measures tissue characteristics in the vicinity of the electrodes, not intervening lung water: implications for heart failure monitoring. J Clin Monit Comput 29 (2015), 65–76.